Ask Your Biostatistician – Adaptive Clinical Trial Design

Ask Your Biostatistician

Adaptive Clinical Trial Design

Turning Complexity into Competitive Advantage
Expert Insights | Practical Strategies

Adaptive clinical trials are reshaping drug development, enabling faster decisions, improved efficiency, and better patient outcomes. But they also introduce operational complexity and increased regulatory expectations.

Listen to the latest episode in our ‘Ask your Biostatistician’ series and learn how to successfully design and manage adaptive trials in alignment with International Council for Harmonisation (ICH E20).

What you will learn

The fundamentals of adaptive trial design
Common adaptations (sample size re-estimation, interim analyses, randomization strategies)
How master protocols (basket, umbrella, MAMS) accelerate development
Key data management challenges (interim locks, data quality, traceability)
Regulatory expectations and engagement strategies

Complete the form to download the on-demand recording and hear directly from our experts as they show you how adaptive design is about planning smarter upfront, enabling flexibility, faster learning, and better decisions without sacrificing scientific rigor.